Adverse Pregnancy Outcomes With Isoniazid Preventive Therapy in HIV
Date: 03/09/2018
Publication:
Infectious Disease Advisor
Isoniazid preventive therapy (IPT) for tuberculosis in pregnant women with HIV was associated with excess adverse pregnancy outcomes and may warrant a reassessment of the current World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) guidelines, according to a poster presented at CROI 2018, held from March 4-7 in Boston, Massachusetts.